2B70.DE vs. WELP.DE
2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) and WELP.DE (HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF) are both Health & Biotech Equities funds - 2B70.DE tracks the Nasdaq Biotechnology while WELP.DE tracks the MSCI World/Energy NR USD. Both are passively managed. Over the past 3 years, 2B70.DE returned 14.71%/yr vs 12.49%/yr for WELP.DE. At a 0.14 correlation, their price movements are largely independent. 2B70.DE charges 0.35%/yr vs 0.59%/yr for WELP.DE.
Performance
2B70.DE vs. WELP.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B70.DE achieves a 14.41% return, which is significantly lower than WELP.DE's 25.35% return.
2B70.DE
- 1D
- 0.86%
- 1M
- 10.24%
- YTD
- 14.41%
- 6M
- 14.41%
- 1Y
- 54.92%
- 3Y*
- 14.71%
- 5Y*
- 6.01%
- 10Y*
- —
WELP.DE
- 1D
- 0.00%
- 1M
- -7.19%
- YTD
- 25.35%
- 6M
- 26.72%
- 1Y
- 34.31%
- 3Y*
- 12.49%
- 5Y*
- —
- 10Y*
- —
2B70.DE vs. WELP.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 14.41% | 18.57% | 4.69% | 2.49% | 2.00% |
WELP.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 25.35% | -1.54% | 7.90% | 0.25% | 5.34% |
Correlation
The correlation between 2B70.DE and WELP.DE is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2022 | 0.14 |
The correlation between 2B70.DE and WELP.DE shifts across timeframes, from -0.08 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. WELP.DE — Risk / Return Rank
2B70.DE
WELP.DE
2B70.DE vs. WELP.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| 2B70.DE | WELP.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.47 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.31 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 8.71 | 2.80 | +5.91 |
| Martin ratioReturn relative to average drawdown | 25.37 | 8.57 | +16.80 |
Loading charts...
Drawdowns
2B70.DE vs. WELP.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.92%, which is greater than WELP.DE's maximum drawdown of -23.55%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and WELP.DE.
Loading charts...
Drawdown Indicators
| 2B70.DE | WELP.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.92% | -23.55% | -7.37% |
Max Drawdown (1Y)Largest decline over 1 year | -6.28% | -12.22% | +5.94% |
Max Drawdown (3Y)Largest decline over 3 years | -29.42% | -23.55% | -5.87% |
Max Drawdown (5Y)Largest decline over 5 years | -30.92% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -11.07% | +11.07% |
Average DrawdownAverage peak-to-trough decline | -11.75% | -7.79% | -3.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.16% | 3.99% | -1.83% |
Volatility
2B70.DE vs. WELP.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE) have volatilities of 6.66% and 6.59%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B70.DE | WELP.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.66% | 6.59% | +0.07% |
Volatility (6M)Calculated over the trailing 6-month period | 15.00% | 16.90% | -1.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.69% | 19.54% | +0.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.49% | 20.07% | +0.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.35% | 20.07% | +2.28% |
2B70.DE vs. WELP.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is lower than WELP.DE's 0.59% expense ratio.
Dividends
2B70.DE vs. WELP.DE - Dividend Comparison
2B70.DE has not paid dividends to shareholders, while WELP.DE's dividend yield for the trailing twelve months is around 3.05%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% |
WELP.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 3.05% | 3.78% | 3.64% | 0.79% |
Frequently Asked Questions
2B70.DE and WELP.DE have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B70.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B70.DE is cheaper with a 0.35% expense ratio, compared with 0.59% for WELP.DE.
2B70.DE tracks Nasdaq Biotechnology, while WELP.DE tracks MSCI World/Energy NR USD. They also come from different issuers: iShares and Amundi. Their fees differ too: 0.35% for 2B70.DE and 0.59% for WELP.DE.
Find the right allocation for 2B70.DE and WELP.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer